This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lindström, M. Articles by Korkeala, H. Search for Related Content PubMed PubMed Citation Articles by Lindström, M. Articles by Korkeala, H.

Laboratory Diagnostics of Botulism

Department of Food and Environmental Hygiene, University of Helsinki, Helsinki, Finland

Botulism is a potentially lethal paralytic disease caused by botulinum neurotoxin. Human pathogenic neurotoxins of types A, B, E, and F are produced by a diverse group of anaerobic spore-forming bacteria, including Clostridium botulinum groups I and II, Clostridium butyricum, and Clostridium baratii. The routine laboratory diagnostics of botulism is based on the detection of botulinum neurotoxin in the patient. Detection of toxin-producing clostridia in the patient and/or the vehicle confirms the diagnosis. The neurotoxin detection is based on the mouse lethality assay. Sensitive and rapid in vitro assays have been developed, but they have not yet been appropriately validated on clinical and food matrices. Culture methods for C. botulinum are poorly developed, and efficient isolation and identification tools are lacking. Molecular techniques targeted to the neurotoxin genes are ideal for the detection and identification of C. botulinum, but they do not detect biologically active neurotoxin and should not be used alone. Apart from rapid diagnosis, the laboratory diagnostics of botulism should aim at increasing our understanding of the epidemiology and prevention of the disease. Therefore, the toxin-producing organisms should be routinely isolated from the patient and the vehicle. The physiological group and genetic traits of the isolates should be determined.

This article has been cited by other articles:

• Macdonald, T. E., Helma, C. H., Ticknor, L. O., Jackson, P. J., Okinaka, R. T., Smith, L. A., Smith, T. J., Hill, K. K. (2008). Differentiation of Clostridium botulinum Serotype A Strains by Multiple-Locus Variable-Number Tandem-Repeat Analysis. Appl. Environ. Microbiol. 74: 875-882 [Abstract] [Full Text]  
• Konig, K., Ringe, H., Dorner, B. G., Diers, A., Uhlenberg, B., Muller, D., Varnholt, V., Gaedicke, G. (2007). Atypical Tetanus in a Completely Immunized 14-Year-Old Boy. Pediatrics 120: e1355-e1358 [Abstract] [Full Text]  
• Paul, C. J., Twine, S. M., Tam, K. J., Mullen, J. A., Kelly, J. F., Austin, J. W., Logan, S. M. (2007). Flagellin Diversity in Clostridium botulinum Groups I and II: a New Strategy for Strain Identification. Appl. Environ. Microbiol. 73: 2963-2975 [Abstract] [Full Text]  
• Fenicia, L., Anniballi, F., De Medici, D., Delibato, E., Aureli, P. (2007). SYBR Green Real-Time PCR Method To Detect Clostridium botulinum Type A. Appl. Environ. Microbiol. 73: 2891-2896 [Abstract] [Full Text]  
• Keto-Timonen, R., Heikinheimo, A., Eerola, E., Korkeala, H. (2006). Identification of Clostridium Species and DNA Fingerprinting of Clostridium perfringens by Amplified Fragment Length Polymorphism Analysis. J. Clin. Microbiol. 44: 4057-4065 [Abstract] [Full Text]